fMRI decoded neurofeedback being tested for therapy to reduce PTSD, phobias

Scientists at the ATR Computational Neuroscience Lab in Japan are using a new technique, called fMRI decoded neurofeedback (DecNef) in hopes to treat patients suffering from post-traumatic stress disorder (PTSD) and phobias. 

Data suggests that this approach is somewhat promising because it has helped patients in reducing anxieties triggered by specific memories, without asking them to think about them conciously. 

Lead researcher Mitsuo Kawato hopes that this study will become another way to treat patients. Exposure therapy accounts for a 40 percent drop-out rate amongst PTSD patients.

View full article: 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.